Studies on the antimicrobial potential of the cardiovascular drug lacidipine

In Vivo

Volumn 21, Issue 5, 2007, Pages 847-850

  Dasgupta, Asish ^a   Jeyaseeli, L ^a   Dutta, Noton Kumar ^b   Mazumdar, Kaushiki ^b   Karak, Prithviraj ^a   Dastidar, Sujata G ^a   Motohashi, Noboru ^c   Shirataki, Yoshiaki ^d  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF KALYANI   (India)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^d JOSAI UNIVERSITY   (Japan)

Author keywords

Antimicrobial activity; Cardiovascular drug; Lacidipine; Non antibiotic

Indexed keywords

CARDIOVASCULAR AGENT; LACIDIPINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS; BACTERIOSTASIS; CHI SQUARE TEST; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG SCREENING; DRUG STRUCTURE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; KLEBSIELLA; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PROTECTION; PSEUDOMONAS; SALMONELLA; SALMONELLOSIS; SHIGELLA; STAPHYLOCOCCUS AUREUS; SWISS WEBSTER MOUSE; VIBRIO CHOLERAE;

EID: 35648942151     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Molnár J, Mandi Y and Király J: Antibacterial effect of some phenothiazine compounds and the R-factor elimination by chlorpromazine. Acta Microbiol Acad Sci Hung 23: 45-54, 1976.
2. Dastidar SG, Saha PK, Sanyamat B and Chakrabarty AN: Antibacterial activities of ambodryl and benadryl. J Appl Bact 41: 209-214, 1976.
3. Chattopadhyay D, Dastidar SG and Chakrabarty AN: Antimicrobial property of methdilazine and its synergism with antibiotics and some chemotherapeutic agents. Arzneim-Forsch/Drug Res (FRG) 38: 869-872, 1988.
4. Chakrabarty AN, Acharya DP, Niyogi DK and Dastidar SG: Drug interaction of some non-conventional antimicrobial chemotherapeutic agents with special reference to promethazine. Indian J Med Res 89: 233-237, 1989.
5. Dastidar SG, Jairaj J, Mookherjee M and Chakrabarty AN: Studies on antimicrobial effect of the antihistaminic phenothiazine trimeprazine tartarate. Acta Microbiol Immun Hung 44: 241-247, 1997.
6. Dash SK, Dastidar SG and Chakrabarty AN: Antimicrobial activity of promazine hydrochloride. Indian J Exp Biol 15: 324-326, 1977.
7. Manna KK and Dastidar SG: The anti-hypertensive drug propranolol hydrochloride (carditap): its antibacterial property. Proc VI Natl Cong IAMM. Chakrabarty AN and Dastidar SG (eds.). Calcutta, India. Image India, pp. 133-141, 1984.
8. Dastidar SG, Mondal U, Niyogi S and Chakrabarty AN: Antibacterial property of methyl-DOPA and development of cross-resistance in m-DOPA mutants. Indian J Med Res 84: 142-147, 1986.
9. Dastidar SG, Das S, Mookerjee M, Chattopadhyay D, Ray S and Chakrabarty AN: Antibacterial activity of local anaesthetics procaine and lignocaine. Indian J Med Res 87: 506-508, 1988.
10. Annadurai S, Basu S, Ray S, Dastidar SG and Chakrabarty AN: Antimicrobial activity of the antiinflammatory agent diclofenac sodium. Indian J Exp Biol 36: 86-90, 1998.
11. Dastidar SG, Ganguly K, Chaudhuri K and Chakrabarty AN: The antibacterial action of diclofenac shown by inhibition of DNA synthesis. Int J Antimicrob Agents 14: 249-251, 2000.
12. Mazumdar R, Ganguly K, Dastidar SG and Chakrabarty AN: Trifluoperazine: A broad spectrum bactericide specially active on staphylococci and vibrios. Int J Antimicrob Agents 18: 403-406, 2001.
13. Dastidar SG, Chaudhuri A, Annadurai S, Ray S, Mookerjee M and Chakrabarty AN: In vitro and in vivo antimicrobial action of fluphenazine. J Chemother 7: 201-206, 1995.
14. Kumar AK, Ganguly K, Mazumdar K, Dutta NK, Dastidar SG and Chakrabarty AN: Amlodipine: a cardiovascular drug with powerful antimicrobial property. Acta Microbiol Pol 52(3): 285-292, 2003.
15. Mazumdar K, Ganguly K, Kumar KA, Dutta NK, Chakrabarty AN and Dastidar SG: Antimicrobial potentiality of new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride. Microbiol Res 158: 259-264, 2003.
16. Karak P, Kumar KA, Mazumdar K, Mookerjee M and Dastidar SG: Antibacterial potential of an antispasmodic drug dicyclomine hydrochloride. Indian J Med Res 118: 192-196, 2003.
17. Kristiansen JE: The antimicrobial activity of non-antibiotics. Acta Path Microbiol Scand 30(Suppl.): 7-19, 1992.
18. Collee FG, Miles RS and Watt B: In: Collee JG, Fraser AG, Marmion BP and Simmons A (eds.). Mackie & McCartney's Practical Medical Microbiology, 14th ed. New York, Churchill Livingstone, pp. 131-150, 1996.
19. National Committee for Clinical Laboratory Standards. Methods for Dilution in Antimicrobial Susceptibility Tests; Approved Standard, M2-A5 (abstract). NCCLS, Villanova, PA USA, 1993.
20. McFarland J: J Am Med Assoc 49: 1176-1178, 1907.
21. Reed LJ and Muench H: A simple method of estimating fifty percent end points. American J Hyg 27: 493-497, 1938.
22. Cristofori P, Lanzoni A, Quartaroli M, Pastorino AM, Zancanaro C, Cominacini L, Gaviraghi G and Turton J: The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse. J Hypertension 18(10): 1429-1436, 2000.